Education
M.S. in Applied Microeconomics and Finance, Sloan School of Management, Massachusetts Institute of Technology; M.A. in Economics, University of Western Ontario; A.B. in Economics, Vassar College
Paul E. Greenberg
Managing Principal and Co-director, Health Economics
Summary of experience
Co-director of the firm's Health Care practice, Paul Greenberg specializes in the economics of the health care sector, both in complex business litigation and in health outcomes research. He has consulted in a variety of cases involving claims of anticompetitive behavior, patent infringement, drug-related injury, and inappropriate marketing and pricing practices, and has developed damage assessments in a range of commercial litigation matters.
Mr. Greenberg has consulted to pharmaceutical and biotechnology companies concerning the pharmacoeconomic profile of specific diseases and medical products and performed pharmacoeconomic studies for major biopharmaceutical companies. His health economics research has been published in key medical, health economics, and managed care journals. He was the lead author of the landmark cost-of-illness study that estimated the annual costs of depression, the most widely cited health economics article to appear in the medical literature since its publication.
Mr. Greenberg is a Task Force Consultant to the Centers for Disease Control (CDC)
Guide to Community Preventive Services Committee on Mental Health. He also serves on the editorial boards of
PharmacoEconomics, the
Journal of Medical Economics,
The Open Pharmacoeconomics & Health Economics Journal, and
Expert Opinion on Pharmacotherapy, and was for many years on the editorial board of
Expert Review of Pharmacoeconomics and Outcomes Research.
En Français